Examples of 'anti-thrombotic' in a sentence
Meaning of "anti-thrombotic"
anti-thrombotic (adjective) - describing a substance or medication that helps prevent the formation of blood clots
How to use "anti-thrombotic" in a sentence
Basic
Advanced
anti-thrombotic
They can be used as anti-thrombotic medication.
Anti-thrombotic treatment is therefore more prolonged in treated patients.
These results demonstrate a powerful anti-thrombotic effect.
Moreover, the anti-thrombotic properties are also influenced by the crystallinity.
A medical device coating having an anti-thrombotic conjugate.
In vivo anti-thrombotic effects in rats may also be utilized for evaluation.
The compositions can also be used in anti-thrombotic treatment.
Using this model, the anti-thrombotic activity of FXaI was compared with that of heparin.
The results demonstrate its powerful anti-thrombotic activity.
Such agents include anti-thrombotic peptides and pseudopeptides capable of inhibiting platelet aggregation.
The drug used is selected to exhibit an anti-thrombotic effect.
There are large numbers of anti-thrombotic agents available to treat these conditions.
The first coating comprises a suitable anti-thrombotic agent.
These results demonstrate the anti-thrombotic and thrombolytic effects of glycine betaine.
Consensus and multidisciplinary view of the management of anti-thrombotic treatment.
See also
The anti-thrombotic agent may be affixed utilizing any technique as briefly described above.
These compositions have previously been described as being useful as anti-thrombotic agents.
The shortest pentasaccharide having potent anti-thrombotic activity is characterised by the formula,.
Compounds of the invention may be administered in combination with an anti-thrombotic agent.
Low molecular weight heparins of interest are anti-thrombotic and anticoagulant at their optimal concentration.
Use of the composition according to claim 1 in the preparation of an anti-thrombotic medicament.
Dextran also has anti-thrombotic effects by being able to coat endothelial surfaces and platelets.
The compositions of the invention therefore act as anti-thrombotic agents.
The anti-thrombotic properties of PLLA will now be examined.
The compounds of the invention are pseudopeptides having anti-thrombotic activity.
A method for forming an anti-thrombotic conjugate material, which comprises,.
Thus there is a need for more effective anti-thrombotic therapy.
For example, other anti-thrombotic agents may be added such as heparin.
These factors are known to contribute to the overall anti-thrombotic effect of enoxaparin.
This anti-thrombotic approach, however, is only weakly inhibitory of platelet aggregation.
Segmented polyurethane is known among polymers structurally exhibiting anti-thrombotic properties.
This anti-thrombotic effect lasts more than 80 minutes following the injection.
In clinical studies, patients received prophylactic acetylsalicylic acid or alternative anti-thrombotic therapy.
Such polypeptide constructs may have superior anti-thrombotic effects compared to the monomeric VHH 's.
In one embodiment, a compound of the invention is administered in combination with an anti-thrombotic agent.
A method of making a pharmacologic agent having anti-thrombotic activity, comprising the steps of,.
In one embodiment, compounds of the invention are administered in combination with an anti-thrombotic agent.
Anti-thrombotic and hypolipidemic is also believed to be a benefit of such high levels of omega-3.
It also features an in vivo anti-metastatic ability and in vitro anti-thrombotic function.
For its prevention, an anti-thrombotic therapy is performed by systemic medication, usually through a vein.
These data identify new targets with a potential interest of anti-thrombotic therapy.
Peptide derivatives of boronic acid, having anti-thrombotic activity, have already been described in the literature.
Biologically active entities of particular interest for immobilization have anti-thrombotic properties.
The anti-thrombotic compound is selected from anti-platelet agents, anticoagulant agents and fibrinolytic agents.
In a preferred embodiment of this aspect of the invention said anti-thrombotic is locally acting.
The anti-thrombotic efficacy of the above-described three configurations is illustrated in Figure 80.
It is stated that these antibodies and fragments can be used as anti-thrombotic agents.
Accordingly, the anti-thrombotic salts of the disclosure may be combined and / or co-administered with an NSAID.
Injection regimens in order to attain a continuous plasma level of the anti-thrombotic agents.
Drotrecogin An anti-thrombotic profibrinolytic anti-inflammatory enzyme.
